Recent advances in molecular mechanisms to improve the efficacy of CAR-T cell therapy for viral diseases, cancer, and autoimmune diseases
Hany E Marei, Giacomo Pozzoli, Sara Caratelli, Carlo Cenciarelli · 2026
Read Recent advances in molecular mechanisms to improve the efficacy of CAR-T cell therapy for viral diseases, cancer, and autoimmune diseases by Hany E Marei, Giacomo Pozzoli, Sara Caratelli, Carlo Cenciarelli (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13555888.txt.
Description
Hany Marei, Giacomo Pozzoli, Sara Caratelli, and Carlo Cenciarelli reviewed ways to sharpen engineered T cell therapy in a 2026 paper. The therapy transformed blood cancer care, but solid tumors, chronic virus infections, and autoimmune disease resist it. Targets vary, tissues suppress the cells, and the cells tire or fade.
Recent work treats the cells as programmable systems rather than fixed products. Receptor redesign, gene editing, control of gene switches, fuel rewiring, and built-in safety circuits are now combined. The aim is cells that sense their setting and adapt, living longer and hitting harder only where needed. The review weighs how close these designs are to clinic use, and what blocks them. Raw killing power, the authors say, is no longer the goal.
Catalog record
| CREATOR | Hany E Marei, Giacomo Pozzoli, Sara Caratelli, Carlo Cenciarelli |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 112 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |